|
End-of-day quote
Egyptian Exchange
2026-09-02
|
5-day change | 1st Jan Change | ||
| 1.490 EGP | -0.67% |
|
-0.67% | +30.70% |
| May. 17 | Macro Group Pharmaceutical Q1 consol profit egp 33.3 million | RE |
| Feb. 19 | Macro Group Pharmaceuticals (Macro Capital) S.A.E Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 850M 16.64M 14.36M 13.52M 12.32M 23.03M 1.57B 23.21M 160M 62.14M 804M 62.49M 61.13M 2.64B | P/E 2026 * |
24.8x | P/E 2027 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise Value | 770M 15.08M 13.01M 12.26M 11.17M 20.87M 1.42B 21.03M 145M 56.31M 728M 56.63M 55.39M 2.39B | EV / Sales 2026 * |
0.65x | EV / Sales 2027 * | 0.48x |
| Free-Float |
30.46% | Yield 2026 * |
2.01% | Yield 2027 * | 2.68% |
| 1 day | -0.67% | ||
| 1 week | -0.67% | ||
| Current month | -0.67% | ||
| 1 month | -0.67% | ||
| 3 months | +14.62% | ||
| 6 months | +9.56% | ||
| Current year | +30.70% |
| 1 week | 1.48 |  | 1.54 |
| 1 month | 1.44 | | 1.74 |
| Current year | 1.02 | | 1.74 |
| 1 year | 0.81 | | 4.11 |
| 3 years | 0.81 | | 4.11 |
| 5 years | 0.81 | | 5.28 |
| 10 years | 0.81 | | 5.28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Khaled Kamel
CEO | Chief Executive Officer | - | - |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
Tamer Raouf
SAM | Sales & Marketing | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Sahar El-Sallab
BRD | Director/Board Member | - | 2020-12-31 |
Ahmed Badreldin
BRD | Director/Board Member | 54 | 2020-12-31 |
Ahmed El-Nayeb
CHM | Chairman | - | 2001-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.67% | -0.67% | -53.00% | -38.17% | 16.83M | |
| +0.01% | -2.47% | +57.79% | +108.23% | 1,034B | |
| +1.48% | +1.93% | +54.56% | +71.49% | 654B | |
| +0.67% | -0.45% | +23.50% | +76.60% | 459B | |
| +0.49% | -5.19% | +33.28% | +34.59% | 343B | |
| +0.27% | +3.26% | +29.76% | +46.97% | 307B | |
| +0.12% | -2.11% | +0.60% | +11.93% | 251B | |
| +1.08% | +0.57% | +54.34% | +72.51% | 237B | |
| +2.64% | -1.08% | -15.85% | -53.64% | 202B | |
| -0.21% | +1.03% | +32.74% | +95.19% | 186B | |
| Average | +0.59% | -1.34% | +21.77% | +42.57% | 367.16B | |
| Weighted average by Cap. | +0.63% | -1.31% | +38.85% | +67.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.19B 23.31M 20.11M 18.94M 17.26M 32.26M 2.2B 32.5M 224M 87.04M 1.13B 87.53M 85.62M 3.7B | 1.55B 30.4M 26.23M 24.71M 22.51M 42.08M 2.87B 42.39M 293M 114M 1.47B 114M 112M 4.82B |
| Net income | 206M 4.04M 3.48M 3.28M 2.99M 5.58M 381M 5.63M 38.82M 15.07M 195M 15.15M 14.82M 640M | 283M 5.54M 4.78M 4.51M 4.1M 7.67M 524M 7.73M 53.34M 20.7M 268M 20.82M 20.36M 879M |
| Net Debt | -79.7M -1.56M -1.35M -1.27M -1.16M -2.16M -147M -2.18M -15.02M -5.83M -75.4M -5.86M -5.73M -248M | -110M -2.15M -1.86M -1.75M -1.6M -2.98M -204M -3M -20.73M -8.05M -104M -8.09M -7.91M -342M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | EGP 1.490 | -0.67% | 35,657,959 |
| 26-09-01 | EGP 1.500 | 0.00% | 50,278,940 |
| 26-08-31 | EGP 1.500 | +0.67% | 41,192,046 |
| 26-08-30 | EGP 1.490 | -0.67% | 29,928,128 |
| 26-08-26 | EGP 1.500 | -0.66% | 28,419,639 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.490EGP
Average target price
1.570EGP
Spread / Average Target
+5.37%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- MCRO Stock
Select your edition
All financial news and data tailored to specific country editions
